Hollsteen
← Qualcomm

Equity incl. NCI

Balance – as of period end · $B

QuartersFiscal years

$BEquity incl. NCI · Q1 FY2016: $30.2B · 10-Q 0001234452-16-000352 filed Jan 27, 2016Equity incl. NCI · Q2 FY2016: $29.6B · 10-Q 0001234452-16-000429 filed Apr 20, 2016Equity incl. NCI · Q3 FY2016: $30.6B · 10-Q 0001234452-16-000483 filed Jul 20, 2016Equity incl. NCI · Q4 FY2016: $31.8B · 10-K 0001234452-16-000552 filed Nov 2, 2016Equity incl. NCI · Q1 FY2017: $31.2B · 10-Q 0001234452-17-000028 filed Jan 25, 2017Equity incl. NCI · Q2 FY2017: $31.3B · 10-Q 0001234452-17-000077 filed Apr 19, 2017Equity incl. NCI · Q3 FY2017: $31.3B · 10-Q 0001234452-17-000154 filed Jul 19, 2017Equity incl. NCI · Q4 FY2017: $30.7B · 10-K 0001728949-19-000072 filed Nov 6, 2019Equity incl. NCI · Q1 FY2018: $23.9B · 10-Q 0001728949-19-000036 filed May 1, 2019Equity incl. NCI · Q2 FY2018: $23.7B · 10-Q 0001728949-19-000036 filed May 1, 2019Equity incl. NCI · Q3 FY2018: $23.0B · 10-Q 0001728949-19-000055 filed Jul 31, 2019Equity incl. NCI · Q4 FY2018: $807M · 10-K 0001728949-19-000072 filed Nov 6, 2019Equity incl. NCI · Q1 FY2019: $3.6B · 10-Q 0001728949-19-000012 filed Jan 30, 2019Equity incl. NCI · Q2 FY2019: $3.9B · 10-Q 0001728949-19-000036 filed May 1, 2019Equity incl. NCI · Q3 FY2019: $5.5B · 10-Q 0001728949-19-000055 filed Jul 31, 2019Equity incl. NCI · Q4 FY2019: $4.9B · 10-K 0001728949-19-000072 filed Nov 6, 2019Equity incl. NCI · Q1 FY2020: $4.5B · 10-Q 0001728949-20-000011 filed Feb 5, 2020Equity incl. NCI · Q2 FY2020: $3.0B · 10-Q 0001728949-20-000031 filed Apr 29, 2020Equity incl. NCI · Q3 FY2020: $3.3B · 10-Q 0001728949-20-000057 filed Jul 29, 2020Equity incl. NCI · Q4 FY2020: $6.1B · 10-K 0001728949-20-000067 filed Nov 4, 2020Equity incl. NCI · Q1 FY2021: $7.4B · 10-Q 0001728949-21-000022 filed Feb 3, 2021Equity incl. NCI · Q2 FY2021: $7.4B · 10-Q 0001728949-21-000043 filed Apr 28, 2021Equity incl. NCI · Q3 FY2021: $8.2B · 10-Q 0001728949-21-000066 filed Jul 28, 2021Equity incl. NCI · Q4 FY2021: $9.9B · 10-K 0001728949-21-000076 filed Nov 3, 2021Equity incl. NCI · Q1 FY2022: $11.3B · 10-Q 0001728949-22-000012 filed Feb 2, 2022Equity incl. NCI · Q2 FY2022: $13.3B · 10-Q 0001728949-22-000026 filed Apr 27, 2022Equity incl. NCI · Q3 FY2022: $16.0B · 10-Q 0001728949-22-000040 filed Jul 27, 2022Equity incl. NCI · Q4 FY2022: $18.0B · 10-K 0000804328-22-000021 filed Nov 2, 2022Equity incl. NCI · Q1 FY2023: $18.8B · 10-Q 0000804328-23-000006 filed Feb 2, 2023Equity incl. NCI · Q2 FY2023: $19.7B · 10-Q 0000804328-23-000023 filed May 3, 2023Equity incl. NCI · Q3 FY2023: $20.7B · 10-Q 0000804328-23-000043 filed Aug 2, 2023Equity incl. NCI · Q4 FY2023: $21.6B · 10-K 0000804328-23-000055 filed Nov 1, 2023Equity incl. NCI · Q1 FY2024: $23.1B · 10-Q 0000804328-24-000017 filed Jan 31, 2024Equity incl. NCI · Q2 FY2024: $24.5B · 10-Q 0000804328-24-000039 filed May 1, 2024Equity incl. NCI · Q3 FY2024: $24.7B · 10-Q 0000804328-24-000056 filed Jul 31, 2024Equity incl. NCI · Q4 FY2024: $26.3B · 10-K 0000804328-24-000075 filed Nov 6, 2024Equity incl. NCI · Q1 FY2025: $26.9B · 10-Q 0000804328-25-000011 filed Feb 5, 2025Equity incl. NCI · Q2 FY2025: $27.7B · 10-Q 0000804328-25-000031 filed Apr 30, 2025Equity incl. NCI · Q3 FY2025: $27.2B · 10-Q 0000804328-25-000045 filed Jul 30, 2025Equity incl. NCI · Q4 FY2025: $21.2B · 10-K 0000804328-25-000085 filed Nov 5, 2025Equity incl. NCI · Q1 FY2026: $23.1B · 10-Q 0000804328-26-000017 filed Feb 4, 2026Equity incl. NCI · Q2 FY2026: $27.3B · 10-Q 0000804328-26-000061 filed Apr 29, 2026Equity incl. NCI · Q3 FY2026: $27.7B · 10-Q 0000804328-26-000086 filed Jul 29, 20263.027.730.231.8Q1 FY2016Q3 FY2026Q2 FY2020
$BEquity incl. NCI · Q2 FY2019: $3.9B · 10-Q 0001728949-19-000036 filed May 1, 2019Equity incl. NCI · Q3 FY2019: $5.5B · 10-Q 0001728949-19-000055 filed Jul 31, 2019Equity incl. NCI · Q4 FY2019: $4.9B · 10-K 0001728949-19-000072 filed Nov 6, 2019Equity incl. NCI · Q1 FY2020: $4.5B · 10-Q 0001728949-20-000011 filed Feb 5, 2020Equity incl. NCI · Q2 FY2020: $3.0B · 10-Q 0001728949-20-000031 filed Apr 29, 2020Equity incl. NCI · Q3 FY2020: $3.3B · 10-Q 0001728949-20-000057 filed Jul 29, 2020Equity incl. NCI · Q4 FY2020: $6.1B · 10-K 0001728949-20-000067 filed Nov 4, 2020Equity incl. NCI · Q1 FY2021: $7.4B · 10-Q 0001728949-21-000022 filed Feb 3, 20213.07.43.9Q2 FY2019Q1 FY2021Q2 FY2020
Q2 FY2020
3.0$B
All values (43)
PeriodValue ($B)Status
Q3 FY202627.7reported
Q2 FY202627.3reported
Q1 FY202623.1reported
Q4 FY202521.2reported
Q3 FY202527.2reported
Q2 FY202527.7reported
Q1 FY202526.9reported
Q4 FY202426.3reported
Q3 FY202424.7reported
Q2 FY202424.5reported
Q1 FY202423.1reported
Q4 FY202321.6reported
Q3 FY202320.7reported
Q2 FY202319.7reported
Q1 FY202318.8reported
Q4 FY202218.0reported
Q3 FY202216.0reported
Q2 FY202213.3reported
Q1 FY202211.3reported
Q4 FY20219.9reported
Q3 FY20218.2reported
Q2 FY20217.4reported
Q1 FY20217.4reported
Q4 FY20206.1reported
Q3 FY20203.3reported
Q2 FY20203.0reported
Q1 FY20204.5reported
Q4 FY20194.9reported
Q3 FY20195.5reported
Q2 FY20193.9reported
Q1 FY20193.6reported
Q4 FY20180.8reported
Q3 FY201823.0reported
Q2 FY201823.7reported
Q1 FY201823.9reported
Q4 FY201730.7reported
Q3 FY201731.3reported
Q2 FY201731.3reported
Q1 FY201731.2reported
Q4 FY201631.8reported
Q3 FY201630.6reported
Q2 FY201629.6reported
Q1 FY201630.2reported

CSV with all sources · Technical ID: equity_total

More metrics for Qualcomm

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$3.0B
Period
Q2 FY2020, ended Mar 29, 2020 · as of Mar 29, 2020 (balance as of date, not a sum)
Source
10-Q, filed Apr 29, 2020 · 0001728949-20-000031
Location
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$3.0BApr 29, 202010-Q 0001728949-20-000031reported · confidence 1. · current